| Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections E Zmievskaya, A Valiullina, I Ganeeva, A Petukhov, A Rizvanov, E Bulatov Biomedicines 9 (1), 59, 2021 | 82 | 2021 |
| Adoptive Immunotherapy beyond CAR T-Cells A Titov, E Zmievskaya, I Ganeeva, A Valiullina, A Petukhov, ... Cancers 13 (4), 743, 2021 | 73 | 2021 |
| Knowns and Unknowns about CAR-T Cell Dysfunction A Titov, Y Kaminskiy, I Ganeeva, E Zmievskaya, A Valiullina, ... Cancers 14 (4), 1078, 2022 | 37 | 2022 |
| Promising new tools for targeting p53 mutant cancers: Humoral and cell-based immunotherapies V Chasov, M Zaripov, R Mirgayazova, R Khadiullina, E Zmievskaya, ... Frontiers in Immunology 12, 707734, 2021 | 30 | 2021 |
| Evaluation of CAR-T Cells’ Cytotoxicity against Modified Solid Tumor Cell Lines AK Valiullina, EA Zmievskaya, IA Ganeeva, MN Zhuravleva, EE Garanina, ... Biomedicines 11 (2), 626, 2023 | 25 | 2023 |
| Recent Advances in the Development of Bioreactors for Manufacturing of Adoptive Cell Immunotherapies I Ganeeva, E Zmievskaya, A Valiullina, A Kudriaeva, R Miftakhova, ... Bioengineering 9 (12), 808, 2022 | 22 | 2022 |
| Encapsulation of the quercetin with interpolyelectrolyte complex based on pillar [5] arenes A Nazarova, L Yakimova, O Mostovaya, T Kulikova, O Mikhailova, ... Journal of Molecular Liquids 368, 120807, 2022 | 7 | 2022 |
| Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies V Chasov, E Zmievskaya, I Ganeeva, E Gilyazova, D Davletshin, ... Antibodies 13 (1), 10, 2024 | 3 | 2024 |
| Adoptive Immunotherapy beyond CAR T-Cells. Cancers 2021, 13, 743 A Titov, E Zmievskaya, I Ganeeva, A Valiullina, A Petukhov, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 3 | 2021 |
| Artificial Extracellular Vesicles Generated from T Cells Using Different Induction Techniques EA Zmievskaya, SA Mukhametshin, IA Ganeeva, EM Gilyazova, ... Biomedicines 12 (4), 919, 2024 | 2 | 2024 |
| Asymmetric T-cell division: insights from cutting-edge experimental techniques and implications for immunotherapy Y Kaminskiy, I Ganeeva, V Chasov, A Kudriaeva, E Bulatov Frontiers in Immunology 15, 1301378, 2024 | 1 | 2024 |
| The Effect of Macrophage Polarization on Cytokine Release in CAR-T Antitumor Response E Zmievskaya, A Valiullina, M Zhuravleva, AR Rakhmatullina, I Ganeeva, ... Blood 136, 22, 2020 | 1 | 2020 |
| Systemic lupus erythematosus therapeutic strategy: From immunotherapy to gut microbiota modulation. V Chasov, E Zmievskaya, I Ganeeva, E Gilyazova, D Davletshin, ... Journal of Biomedical Research, 1-16, 2024 | | 2024 |
| 133P Cytotoxic efficacy of artificial vesicles obtained from CAR-T cells by ultrasonication E Zmievskaya, S Mukhametshin, I Ganeeva, E Gilyazova, A Rogov, ... ESMO Open 8 (1), 2023 | | 2023 |
| 88P Evaluating the infiltration of anti-NKG2DL CAR-T cells into a 3D cell culture developed in a Vitvo cartridge bioreactor A Valiullina, E Zmievskaya, I Ganeeva, M Zhuravleva, E Bulatov ESMO Open 8 (1), 2023 | | 2023 |
| Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T V Chasov, E Zmievskaya, I Ganeeva, E Gilyazova, D Davletshin, ... Preprints, 2023 | | 2023 |
| Сytotoxic effect of CAR-T cells against modified MCF-7 breast cancer cell line AK Valiullina, EA Zmievskaya, IA Ganeeva, MN Zhuravleva, EE Garanina, ... Molecular Biology Research Communications 12 (4), 139, 2023 | | 2023 |
| Effect of p53 activator Nutlin-3a on populations of immune cells obtained from healthy donor and patient with multiple sclerosis I Ganeeva, A Valiullina, E Zmievskaya, A Rizvanov, E Bulatov CELL DEATH DISCOVERY 8, 9-9, 2022 | | 2022 |
| 82P Obtaining microvesicles from T-lymphocytes using various methods of induction E Zmievskaya, S Mukhametshin, A Valiullina, I Ganeeva, E Bulatov, ... Annals of Oncology 33, S1408, 2022 | | 2022 |
| Effect of p53 activator nutlin-3a on cytokine release in peripheral blood mononuclear cells of healthy donor and patient with multiple sclerosis I Ganeeva, A Valiullina, E Zmievskaya, A Rizvanov, E Bulatov EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 52, 2022 | | 2022 |
